Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | STAT1 | P42224 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | PRNP | P04156 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13228906 | 0.89 | NPSR1 (0.44) | LMNANPSR1MEN1GAATSHR | |
| SCHEMBL7668283 | 0.88 | NPSR1 (0.43) | LMNANPSR1MEN1GAATSHR | |
| SCHEMBL9423133 | 0.85 | TSHR (0.47) | LMNANPSR1MEN1GAATSHR | |
| SCHEMBL9079647 | 0.82 | LMNA (0.40) | LMNANPSR1MEN1GAATSHR | |
| SCHEMBL18210830 | 0.82 | HSD17B10 (0.58) | LMNANPSR1MEN1GAATSHR | |
| SCHEMBL7698795 | 0.82 | NPSR1 (0.44) | LMNANPSR1MEN1GAATSHR | |
| SCHEMBL8632439 | 0.81 | NPSR1 (0.65) | LMNANPSR1MEN1GAATSHR | |
| SCHEMBL8874894 | 0.80 | RAB9A (0.42) | NPSR1MEN1GAATSHRKMT2A | |
| SCHEMBL8632437 | 0.79 | LMNA (0.44) | LMNANPSR1MEN1GAATSHR | |
| SCHEMBL8185405 | 0.78 | LMNA (0.37) | LMNANPSR1MEN1GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5302714-A | Sapphyrins, derivatives and syntheses | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-04-12 | — | — | US | claimed |
| EP-0515395-A1 | SAPPHYRINS, DERIVATIVES AND SYNTHESIS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-12-02 | — | — | EP | claimed |
| WO-1991009861-A1 | SAPPHYRINS, DERIVATIVES AND SYNTHESIS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-07-11 | — | — | WO | claimed |
| EP-3283493-B1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | UNIV HEALTH NETWORK UHN (CA) | 2020-11-18 | — | — | EP | disclosed |
| US-10729792-B2 | Texaphyrin-phospholipid conjugates and methods of preparing same | UNIVERSITY HEALTH NETWORK (CA) | 2020-08-04 | — | — | US | disclosed |
| US-20180104364-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | UNIVERSITY HEALTH NETWORK (CA) | 2018-04-19 | — | — | US | disclosed |
| US-20180104364-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | UNIVERSITY HEALTH NETWORK (CA) | 2018-04-19 | — | — | US | disclosed |
| WO-2016165006-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | UNIVERSITY HEALTH NETWORK (CA) | 2016-10-20 | — | — | WO | disclosed |
| EP-0885228-B1 | MESO-SUBSTITUTED TRIPYRRANE COMPOUNDS, COMPOSITIONS, AND METHODS FOR MAKING AND USING THE SAME | UNIV BRITISH COLUMBIA (CA) | 2006-05-31 | — | — | EP | disclosed |
| US-6022981-A | KEY INTERMEDIATES IN SYNTHESIZING 5,10-DISUBSTITUTED PORPHYRIN COMPOUNDS OR OTHER 5,10-DISUBSTITUTED POLYPYRROLIC MACROCYCLES. | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2000-02-08 | — | — | US | disclosed |
| US-5919923-A | REACTING ALDEHYDE OR ACETAL WITH STOICHIOMETRIC EXCESS OF PYRROLE IN PRESENCE OF ACID CATALYST, REMOVING SOLVENT BY EVAPORATION TO FORM RESIDUE, REMOVING HIGH MOLECULAR WEIGHT BY-PRODUCTS TO LEAVE DESIRED TRIPYRRANE | BRITISH COLUMBIA, UNIVERSITY OF, THE (CA) | 1999-07-06 | — | — | US | disclosed |
| US-5883246-A | CYCLIZATION OF POLYPYRROLES AND OXIDATION TO FORM POLYPYRROLE MACROCYCLE | QLT PHOTOTHERAPEUTICS, INC. (CA) | 1999-03-16 | — | — | US | disclosed |
| US-5302714-A | Sapphyrins, derivatives and syntheses | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-04-12 | — | — | US | disclosed |
| EP-0515395-A1 | SAPPHYRINS, DERIVATIVES AND SYNTHESIS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-12-02 | — | — | EP | disclosed |
| US-5159065-A | SAPPHYRINS, DERIVATIVES AND SYNTHESES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-10-27 | — | — | US | disclosed |
| WO-1991009861-A1 | SAPPHYRINS, DERIVATIVES AND SYNTHESIS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180104364-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | PLTP, PHOSPHO1, TEX13A | LMNA 781/4885NPSR1 3518/4885MEN1 208/4885 |
| US-10729792-B2 | Texaphyrin-phospholipid conjugates and methods of preparing same | PLTP, PHOSPHO1, TEX13A | LMNA 781/4885NPSR1 3518/4885MEN1 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.